Albany, NY -- (SBWire) -- 12/20/2018 --The global high content screening/imaging market is predicted to rise at a stellar rate during the forecast period 2018-2023 owing to rise in demand for development of new drug molecules. Prevalence of chronic diseases such as HIV AID, Parkinson's disease, and epilepsy, which requires high intensive treatment is expected to boosts the sales rate of the market product. ResearchMoz.us in a report titled, "High Content Screening/Imaging: Technologies and Global Markets", provided an in-depth value chain analysis. The report also consists of various market dynamics such as trends, opportunities, and restraints which are anticipated to have a tremendous impact on the market.

Rise in uptake of content screening /imaging devices to determine and examine toxicity levels in an early stage of drug discovery is resulting in massive product demand. Rapid advancement in technology has bode well with the market. Advancement in technology has resulted in polarization techniques, polarization techniques, automated imaging technology and flow cytometry, and multicolored fluorescence based reagents are anticipated to become major pillars supporting the growth of the market.

Request a Sample PDF with ToC at: https://www.researchmoz.us/enquiry.php?type=S&repid=1929769

These advancements have excruciated toxicities during the drug interactions, which has resulted in greater accuracy of drugs, better stability, increased cost efficiency, and reduced drug discovery times. All these factors have made pharmaceutical manufacturers to incline towards high content screening/imaging products. Better software, new detection methods, and enhanced data visualization tools as that of fluorescence lifetime and multispectral imaging are prognosticated to fuel the demand in market.

Heavy inflow of investments behind research and development activities in cellular science by governmental and private bodies is foreseen to drive the global market. Rising cases of complex genetic disorders and neurological diseases are expected to push the market in the forward direction. The global market for High Content Screening/Imaging is classified on the basis of component, end user, and region. On the basis of end user the market is segregated into companies, laboratories and pathology centers, and academics. Based on component, the market is divided into plate reader, cytometers, imaging device, instrument or platform, light sources, liquid handling instruments, detectors, siRNA screens, OpenHiCaMM software services, software and analytics, consumables, and liquid handling instruments.

On the basis of geography, the market is dominated by North America, owing to presence of major research and healthcare facilities, significant help from the government, and strong regional economy. Europe is prognosticated to witness a strong demand in years to come due to extensive research and development activities in the region. Asia Pacific is predicted to become a key region in the market owing to development of healthcare infrastructure in countries such as China, India, and Malaysia. Some of the major players in the market are Becton, Dickinson and Company, PerkinElmer Inc., Thermo Fisher Scientific, and Cell Signaling Technology.

Contact Us:
Mr. Nachiket
Albany NY - 12207
United States
Tel: +1-518-621-2074
Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG